11.04.2018 08:00:31

07/2018 - Interim Report 1 September 2017 - 28 February 2018


Company Announcement No. 07/2018

 

For further information, please contact:

Martin Riise, Head of Investor Relations
Tel: +45 53 39 22 50

Helle Rexen, Interim Head of Media Relations
Tel: +45 20 74 28 40

About Chr. Hansen
Chr. Hansen is a leading global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as "good bacteria.” Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which makes our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for more than 140 years. We are proud that more than 1 billion people consume products containing our natural ingredients every day.

Attachment

Nachrichten zu Chr. Hansen Holding A-Smehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Chr. Hansen Holding A-Smehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Chr. Hansen Holding A-S 73,64 28,25% Chr. Hansen Holding A-S